Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 533

1.

A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.

Wernicke AG, Goodman RL, Turner BC, Komarnicky LT, Curran WJ, Christos PJ, Khan I, Vandris K, Parashar B, Nori D, Chao KS.

Breast Cancer Res Treat. 2011 Feb;125(3):893-902. doi: 10.1007/s10549-010-1167-6. Epub 2010 Sep 19.

2.

Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance.

Wernicke AG, Shamis M, Sidhu KK, Turner BC, Goltser Y, Khan I, Christos PJ, Komarnicky-Kocher LT.

Am J Clin Oncol. 2013 Feb;36(1):12-9. doi: 10.1097/COC.0b013e3182354bda.

3.

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M.

JAMA. 2011 Feb 9;305(6):569-75. doi: 10.1001/jama.2011.90.

4.

Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.

Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K.

Ann Surg. 2010 Sep;252(3):426-32; discussion 432-3. doi: 10.1097/SLA.0b013e3181f08f32.

PMID:
20739842
5.

Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.

Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, Glass EC, Turner RR.

J Clin Oncol. 2000 Jul;18(13):2553-9. Erratum in: J Clin Oncol 2000 Nov 15;18(22):3877.

PMID:
10893286
6.

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.

Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE; American College of Surgeons Oncology Group..

J Clin Oncol. 2007 Aug 20;25(24):3657-63. Epub 2007 May 7.

PMID:
17485711
7.

Improved axillary staging of breast cancer with sentinel lymphadenectomy.

Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL.

Ann Surg. 1995 Sep;222(3):394-9; discussion 399-401. Review.

8.

[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].

Sávolt A, Musonda P, Mátrai Z, Polgár C, Rényi-Vámos F, Rubovszky G, Kovács E, Sinkovics I, Udvarhelyi N, Török K, Kásler M, Péley G.

Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765. Hungarian.

PMID:
24292111
9.

When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections.

Olaya W, Wong J, Wong J, Morgan J, Kazanjian K, Lum S.

Ann Surg Oncol. 2013 Feb;20(2):627-32. doi: 10.1245/s10434-012-2642-6. Epub 2012 Sep 7.

PMID:
22956069
10.
11.

Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone.

Galper S, Recht A, Silver B, Manola J, Gelman R, Schnitt SJ, Connolly JL, Harris JR.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1157-66.

PMID:
10613308
12.
13.

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N.

Lancet Oncol. 2010 Oct;11(10):927-33. doi: 10.1016/S1470-2045(10)70207-2.

14.

Breast cancer related lymphedema in patients with different loco-regional treatments.

Ozcinar B, Guler SA, Kocaman N, Ozkan M, Gulluoglu BM, Ozmen V.

Breast. 2012 Jun;21(3):361-5. doi: 10.1016/j.breast.2012.03.002. Epub 2012 Mar 27.

PMID:
22460058
15.

Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.

Grills IS, Kestin LL, Goldstein N, Mitchell C, Martinez A, Ingold J, Vicini FA.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):658-70.

PMID:
12788171
16.

Tangential vs. defined radiotherapy in early breast cancer treatment without axillary lymph node dissection: a comparative study.

Nitsche M, Temme N, Förster M, Reible M, Hermann RM.

Strahlenther Onkol. 2014 Aug;190(8):715-21. doi: 10.1007/s00066-014-0681-6. Epub 2014 May 17.

PMID:
24838410
17.

Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients.

Langer I, Kocher T, Guller U, Torhorst J, Oertli D, Harder F, Zuber M.

Breast Cancer Res Treat. 2005 Mar;90(1):85-91.

PMID:
15770531
19.

Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation.

Stranzl H, Mayer R, Ofner P, Peintinger F, Prettenhofer U, Hackl A.

Strahlenther Onkol. 2004 Jan;180(1):31-7.

PMID:
14704842
20.

Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.

Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.

J Surg Oncol. 2004 Oct 1;88(1):4-7; discussion 7-8.

PMID:
15384064

Supplemental Content

Support Center